Correlation Between Moleculin Biotech and Moolec Science

Can any of the company-specific risk be diversified away by investing in both Moleculin Biotech and Moolec Science at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Moleculin Biotech and Moolec Science into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Moleculin Biotech and Moolec Science SA, you can compare the effects of market volatilities on Moleculin Biotech and Moolec Science and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Moleculin Biotech with a short position of Moolec Science. Check out your portfolio center. Please also check ongoing floating volatility patterns of Moleculin Biotech and Moolec Science.

Diversification Opportunities for Moleculin Biotech and Moolec Science

0.04

Correlation Coefficient

Moleculin Biotech  Moolec Science

Significant diversification

The 3 months correlation between Moleculin and Moolec is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding Moleculin Biotech and Moolec Science SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Moolec Science SA and Moleculin Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Moleculin Biotech are associated (or correlated) with Moolec Science. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Moolec Science SA has no effect on the direction of Moleculin Biotech i.e., Moleculin Biotech and Moolec Science go up and down completely randomly.

Pair Corralation between Moleculin Biotech and Moolec Science

Given the investment horizon of 90 days Moleculin Biotech is expected to generate 18.55 times less return on investment than Moolec Science. But when comparing it to its historical volatility, Moleculin Biotech is 1.63 times less risky than Moolec Science. It trades about 0.01 of its potential returns per unit of risk. Moolec Science SA is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  1.33  in Moolec Science SA on April 30, 2025 and sell it today you would earn a total of  0.53  from holding Moolec Science SA or generate 39.85% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	83.87%
Values	Daily Returns

Moleculin Biotech  vs.  Moolec Science SA

Moleculin Biotech

Risk-Adjusted Performance

Very Weak

Over the last 90 days Moleculin Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly weak basic indicators, Moleculin Biotech may actually be approaching a critical reversion point that can send shares even higher in August 2025.

Moolec Science SA

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Moolec Science SA are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal fundamental indicators, Moolec Science showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Moleculin Biotech and Moolec Science

The main advantage of trading using opposite Moleculin Biotech and Moolec Science positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Moleculin Biotech position performs unexpectedly, Moolec Science can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moolec Science will offset losses from the drop in Moolec Science's long position.

The idea behind Moleculin Biotech and Moolec Science SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.